Marshall Wace
BIVV

Marshall Wace’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Marshall Wace’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,664
Closed -$305K – 693
2017
Q4 		$305K Hold
5,664
– – 0.01% 347
2017
Q3 		$323K Hold
5,664
– – 0.02% 305
2017
Q2 		$340K Buy
+5,664
New +$323K 0.02% 270

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Marshall Wace's BIVV Position: Q1 2018 in Review

Marshall Wace sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 5,664 shares — an estimated $305K sold.

Marshall Wace first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $340K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Marshall Wace reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Marshall Wace sold 5,664 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $305K.
  • Marshall Wace first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
  • Marshall Wace's Bioverativ Inc. Common Stock position peaked at $340K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Marshall Wace's 13F filing for Q1 2018, filed 15 May 2018.